Simulations Plus, Inc. SLP 深 滬
已收盤 05-08 16:00:00 美东时间
16.68
+0.620
+3.86%
華盛通- 最 高16.75
- 今 開15.98
- 成交量 24.41万股
- 最 低 15.71
- 昨 收 16.06
- 總市值 3.37亿
- 52周最高 34.01
- 市盈率 靜 --
- 換手率 1.21%
- 52周最低 11.09
- 委 比 48.05%
- 總股本 2020.55万
- 歷史最高 90.08
- 量 比 0.38
- 振 幅 6.48%
- 歷史最低 0.47
- 每 手 1
- 風險率 5.01%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Simulations Plus Partners With Nvidia Over GPU-Accelerated Simulation, AI-Assisted Workflows For Computationally Intensive Modeling Applications Within The Drug Development Lifecycle
Simulations Plus, Inc. (NASDAQ:SLP) ("Simulations Plus" or the "Company"), a global leader in model-informed and AI-accelerated drug development that advances biopharma innovation, today announced the launch of a
05-06 19:56
Certara Strategic Business Divestiture Comes At Right Time, Says Analyst
Certara stock rises after $135 million divestiture to Veristat as analysts weigh MIDD focus and improving biopharma demand.
04-23 03:23
Simulations Plus Partners With Lonza Group, FDA To Develop, Validate Framework For Amorphous SOLID Dispersion Drug Products
Simulations Plus, Inc. (Nasdaq: SLP) ("Simulations Plus" or the "Company"), a global leader in model-informed and AI-accelerated drug development that advances biopharma innovation, today announced a funded research
04-21 20:01
美股大行评级 | 大砍54%！大摩下调Robinhood 目标价从147降至95美元；星座品牌酒业(STZ)获8家大行上调目标价
今日重点评级关注：Ascendiant Capital：维持Allarity Therapeutics"买入"评级，目标价从9.5美元升至9.75美元；Citizens：维持戴夫"跑赢大市"评级，目标价从310美元升至335美元
04-13 14:07
电话会总结 ｜ Simulations Plus(SLP)2026财年Q2业绩电话会核心要点
<span style="color:#999999;">编者按：聚焦公司高管观点与展望，深挖业绩背后的信息，助力投资者把握先机。</span><blockquote><p><span style="color:#fa1432;"><strong>业绩回顾</strong></span></p></blockquote><p>• 根据Simulations Plus业绩会实录，以下是业绩回顾摘要： ## 1. 财务业绩 **第二季度总体表现：** - 总营收达到2,430万美元，同比增长8% - 软件业务营收增长9%，占总营收的60% - 服务业务营收增长8%，占总营收的40% - 调整后EBITDA为870万美元，利润率达36% - 调整后稀释每股收益为0.35美元 **分业务线表现：** - 发现业务营收季度增长19%，过去12个月增长6%，占软件营收的19% - 开发业务营收季度增长12%，过去12个月增长3%，占软件营收的78% - 临床运营业务营收季度下降54%，仅
04-11 12:33
What's Going On With Simulations Plus Stock Friday?
Simulations Plus beats Q2 estimates, trims fiscal 2026 earnings outlook, and keeps sales guidance intact on favorable market conditions.
04-11 01:42
Simulations Plus shares are trading higher after the company reported better-than-expected Q2 financial results.
Simulations Plus shares are trading higher after the company reported better-th...
04-10 04:19
Simulations Plus Lowers FY2026 Adj EPS Guidance from $1.03-$1.10 to $0.75-$0.85 vs $0.54 Est; Affirms FY2026 Sales Guidance of $79.000M-$82.000M vs $80.466M Est
Simulations Plus (NASDAQ:SLP) lowers FY2026 Adj EPS guidance from $1.03-$1.10 to $0.75-$0.85 vs $0.54 analyst estimate. Affirms FY2026 sales outlook from $79.000 million-$82.000 million to $79.000 million-$82.000 million
04-10 04:08
Simulations Plus Q2 Adj. EPS $0.35 Beats $0.20 Estimate, Sales $24.291M Beat $21.665M Estimate
Simulations Plus (NASDAQ:SLP) reported quarterly earnings of $0.35 per share which beat the analyst consensus estimate of $0.20 by 75 percent. This is a 12.9 percent increase over earnings of $0.31 per share from the
04-10 04:07
